ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,602,911 | +4.6% | 842,366 | -8.6% | 0.06% | +22.2% |
Q2 2023 | $2,489,238 | -30.1% | 921,940 | -23.1% | 0.04% | -35.7% |
Q1 2023 | $3,559,061 | +286.6% | 1,198,337 | +228.0% | 0.07% | +288.9% |
Q4 2022 | $920,556 | -21.1% | 365,300 | -43.0% | 0.02% | -18.2% |
Q3 2022 | $1,166,000 | -78.8% | 640,645 | +39.1% | 0.02% | -54.2% |
Q4 2020 | $5,494,000 | -32.4% | 460,500 | -60.9% | 0.05% | -52.9% |
Q3 2020 | $8,125,000 | -11.0% | 1,177,483 | -20.0% | 0.10% | -20.3% |
Q2 2020 | $9,125,000 | +55.0% | 1,471,853 | 0.0% | 0.13% | +29.3% |
Q1 2020 | $5,887,000 | -27.3% | 1,471,853 | 0.0% | 0.10% | -14.7% |
Q4 2019 | $8,095,000 | +63.2% | 1,471,853 | 0.0% | 0.12% | +23.4% |
Q3 2019 | $4,960,000 | – | 1,471,853 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 8,748,629 | $15,923,000 | 0.66% |
Soleus Capital Management, L.P. | 2,640,539 | $4,806,000 | 0.65% |
Omega Fund Management, LLC | 328,196 | $597,000 | 0.22% |
MPM BioImpact LLC | 405,700 | $738,000 | 0.18% |
Bellevue Group AG | 5,898,583 | $10,736,000 | 0.15% |
Rhenman & Partners Asset Management AB | 375,000 | $1,350,000 | 0.14% |
PFM Health Sciences, LP | 1,478,252 | $2,690,000 | 0.10% |
Frazier Life Sciences Management, L.P. | 692,910 | $1,261,000 | 0.10% |
Avidity Partners Management LP | 2,460,000 | $4,477,000 | 0.09% |
Eventide Asset Management | 1,561,251 | $2,841,000 | 0.06% |